Name: Clidinium bromide-[d5]
Brand: BOC Sciences
Price: 699 USD
Availability: MadeToOrder

General Information

Catalog: BLP-009584

Molecular Formula: C22H26BrNO3

Molecular Weight: 437.4

Chemical Structure

Catalog Number

Size

Price

Stock

Quantity

BLP-009584

5 mg

$699

In stock

Description	Clidinium-[d5] bromide is a labelled clidinium bromide. Clidinium bromide is an anticholinergic used as an antispasmodic to reduce stomach acid and decreases intestinal spasms.
Synonyms	Clidinium-D5 bromide; Clidinium-D5 (bromide)
IUPAC Name	(1-methyl-1-azoniabicyclo[2.2.2]octan-3-yl) 2-hydroxy-2-(2,3,4,5,6-pentadeuteriophenyl)-2-phenylacetate;bromide
Related CAS	3485-62-9 (unlabelled)
Canonical SMILES	C[N+]12CCC(CC1)C(C2)OC(=O)C(C3=CC=CC=C3)(C4=CC=CC=C4)O.[Br-]
InChI	InChI=1S/C22H26NO3.BrH/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19;/h2-11,17,20,25H,12-16H2,1H3;1H/q+1;/p-1/i2D,4D,5D,8D,9D;
InChI Key	GKEGFOKQMZHVOW-DIVICVDQSA-M

Clidinium bromide-[d5], a deuterated analogue of clidinium bromide, is commonly utilized in pharmacokinetic and pharmacodynamic investigations. Here are the key applications of Clidinium bromide-[d5]:

Pharmacokinetic Studies: In the realm of pharmacokinetic scrutiny, Clidinium bromide-[d5] plays a pivotal role in unraveling the intricacies of absorption, distribution, metabolism, and excretion (ADME) of clidinium bromide. The deuterated variant enables precise tracking and differentiation from unlabeled compounds, a critical element for ensuring accurate assessments of bioavailability and half-life dynamics.

Drug Interaction Research: Delving into drug interaction dynamics, Clidinium bromide-[d5] emerges as a crucial tool for evaluating the impact of concomitant medications on the metabolism and efficacy of clidinium bromide. Through the utilization of a labeled version, researchers gain the ability to discriminate it from endogenous or co-administered substances, facilitating the identification of potential drug-drug interactions and the optimization of therapeutic protocols.

Analytical Method Development: Within the realm of analytical method innovation, Clidinium bromide-[d5] serves as a cornerstone internal standard in the development and validation of methodologies like liquid chromatography-mass spectrometry (LC-MS). Its stable isotopic labeling ensures precise quantification and consistency across diverse experimental setups, a fundamental aspect in guaranteeing the reliability and reproducibility of analytical outcomes.

Clinical Research: Embarking on a journey of clinical exploration, Clidinium bromide-[d5] stands at the forefront, enabling the in-depth investigation of its pharmacological effects and therapeutic potentials. The isotopic labeling feature empowers precise measurements in human plasma and tissues, thereby fostering a deeper comprehension of its pharmacodynamic profiles. This knowledge can pave the way for enhanced dosing recommendations and expanded therapeutic applications.